Skip to main navigation
PLx Pharma logo PLx Pharma Inc.
PLx Pharma logo

Main navigation

  • Products & Technology
    • PLxGuard Delivery System
    • PLxGuard Pipeline
    • Publications & Research
  • Healthcare Professionals
    • Vazalore 325 mg
    • Vazalore 81 mg
    • PL1100/PL1200 Ibuprofen
  • About PLx
    • Company Overview
  • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Partnership Opportunities
  • Investors
    • News & Events
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Shareholder Services
  • Contact
 
powered by
Custom Search
Sort by:
Relevance
Relevance
Date
Web
 
 
 

Home › Investor Relations › CORRESP

SEC Filing

SEC Filing Details

Document Details

Form
CORRESP
Filing Date
Jan 4, 2021
Document Date
Jan 4, 2021
Form Description
CORRESP
Filing Group
Other
Company
PLx Pharma Inc.
Issuer
PLx Pharma Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Toolkit

  • Print Page
  • Email Alerts
  • RSS Feeds

Investor Relations

  • Investor Relations
  • News & Events
  • Corporate Governance
  • Financial Information
  • Stock Information
  • Shareholder Services
PLx Pharma Inc.

9 Fishers Lane, Suite E
Sparta, NJ 07871
Tel: (973) 409-6541
Fax: (973) 843-6300

Main navigation

  • Products & Technology
    • PLxGuard Delivery System
    • PLxGuard Pipeline
    • Publications & Research
  • Healthcare Professionals
    • Vazalore 325 mg
    • Vazalore 81 mg
    • PL1100/PL1200 Ibuprofen
  • About PLx
    • Company Overview
  • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Partnership Opportunities
  • Investors
    • News & Events
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Shareholder Services
  • Contact
© PLx Pharma Inc. 2021. PLx, PLx Pharma, PLxGuard, and Aspertec are trademarks™ or registered® trademarks of PLx Pharma Inc.